pyrazolanthrone has been researched along with Neuralgia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
He, N; Li, DY; Qu, YJ; Yue, SW | 1 |
Chen, L; Cui, SS; Gao, J; Liu, F; Lu, R; Wang, W; Wang, XX | 1 |
Galeotti, N; Ghelardini, C; Sanna, MD | 1 |
3 other study(ies) available for pyrazolanthrone and Neuralgia
Article | Year |
---|---|
RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling.
Topics: Animals; Anthracenes; Benzothiazoles; Cell Line; Constriction; JNK Mitogen-Activated Protein Kinases; Male; Neuralgia; Neuroinflammatory Diseases; Quinolines; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction | 2021 |
Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats.
Topics: Animals; Anthracenes; Astrocytes; Carbamates; Cells, Cultured; Etanercept; Excitatory Amino Acid Transporter 2; Histone Deacetylase 2; Hyperalgesia; JNK Mitogen-Activated Protein Kinases; Male; Microglia; Minocycline; Neuralgia; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Nerves; Tumor Necrosis Factor-alpha | 2021 |
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
Topics: Animals; Anthracenes; Anti-Retroviral Agents; Brain-Derived Neurotrophic Factor; Caspase 3; Cold Temperature; Hyperalgesia; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Models, Animal; Neuralgia; Protein Kinase Inhibitors; Random Allocation; Spinal Cord; Stavudine; Touch; Zalcitabine | 2016 |